Description

Gefitinib 250mg GEFISTERIS 250 contains Gefitinib 250mg, an oral anti-cancer medicine belonging to the class of EGFR tyrosine kinase inhibitors (TKIs). It is specially designed as a targeted therapy for patients suffering from locally advanced or metastatic non-small cell lung cancer (NSCLC), particularly in cases where tumors exhibit epidermal growth factor receptor EGFR mutations. By directly targeting the EGFR signaling pathway, GEFISTERIS 250 blocks abnormal cell growth, offering a more personalized and effective treatment option with fewer side effects compared to conventional chemotherapy. 🔹 Mechanism of Action GEFISTERIS 250 works by: Blocking EGFR activity – inhibits tyrosine kinase enzyme within cancer cells. Preventing cancer cell growth & spread – halts downstream signaling responsible for tumor progression. Inducing apoptosis – promotes programmed cancer cell death. Targeted precision – primarily affects cancer cells with EGFR mutations, minimizing damage to normal cells. 🔹 Indications & Uses GEFISTERIS 250 (Gefitinib 250mg) is used for the treatment of: Non-Small Cell Lung Cancer (NSCLC) – locally advanced or metastatic cases with EGFR mutation-positive tumors. First-line therapy – in patients with sensitizing EGFR mutations. Alternative therapy – for patients intolerant to or progressing after standard chemotherapy. 🔹 Dosage & Administration Recommended Dose: One tablet (250mg) once daily with or without food. Tablets should be swallowed whole with water. Should be taken at the same time each day. Treatment duration is as directed by the oncologist. ⚠️ Do not crush or chew the tablet. Always follow the doctor’s prescription. 🔹 Benefits of GEFISTERIS 250 ✅ Targeted Therapy: Acts specifically on EGFR-mutated cancer cells. ✅ Improved Quality of Life: Less toxic than traditional chemotherapy. ✅ Oral Convenience: Easy once-daily oral administration. ✅ Effective Disease Control: Delays tumor progression and extends survival. ✅ Symptom Relief: Helps improve breathing, reduces coughing, and improves overall comfort. 🔹 Possible Side Effects Like all medications, Gefitinib may cause some side effects. Common ones include: Skin rash or acne Diarrhea Nausea and vomiting Loss of appetite Weakness or fatigue Eye irritation Dry skin ⚠️ Rare but serious side effects: Interstitial lung disease, liver function abnormalities, severe diarrhea or dehydration. Patients must be monitored regularly. 🔹 Safety Precautions Pregnancy & Lactation: Not recommended during pregnancy or breastfeeding. Liver & Kidney Patients: Dose adjustment may be required; consult physician. Drug Interactions: Avoid using with strong CYP3A4 inducers/inhibitors and certain antacids. Monitoring: Regular lung, liver, and kidney function tests are recommended. 🔹 Storage Instructions Store at room temperature (15°C–30°C). Keep away from direct sunlight and moisture. Keep out of reach of children. 🔹 Why Choose GEFISTERIS 250? Trusted oncology formulation. Effective first-line therapy for EGFR mutation-positive NSCLC. Manufactured with high quality standards ensuring safety & efficacy. Offers patients a personalized treatment approach with significant benefits over standard therapies. ✨ GEFISTERIS 250 (Gefitinib 250mg) is a reliable, advanced, and patient-friendly solution for EGFR mutation-positive NSCLC, giving patients hope for longer survival and better quality of life.